Lord, Abbett & Co’s Akero Therapeutics AKRO Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q2
Sell
-527,004
Closed -$21.3M 504
2025
Q1
$21.3M Buy
+527,004
New +$21.3M 0.08% 280
2023
Q4
Sell
-779,126
Closed -$39.4M 514
2023
Q3
$39.4M Buy
779,126
+472,898
+154% +$23.9M 0.15% 199
2023
Q2
$14.3M Buy
+306,228
New +$14.3M 0.05% 386